Alison Hannah

Alison Hannah

Director/Board Member presso NEOGENOMICS, INC.

Patrimonio netto: 2 M $ in data 31/03/2024

63 anni
Health Services
Health Technology
Consumer Services

Profilo

Alison L.
Hannah
is currently an Independent Director at NeoGenomics, Inc., an Independent Director at Rigel Pharmaceuticals, Inc., a Director at NeoGenomics Laboratories, Inc., and a Member of the American Society of Clinical Oncology, Inc., the American Association for Cancer Research, and the American Society of Hematology.
Previously, she served as a Senior Medical Director at Sugen, Inc. from 1995 to 2000 and as the Chief Medical Officer & Senior Vice President at CytomX Therapeutics, Inc. from 2020 to 2022.
Dr. Hannah received her undergraduate degree from Harvard University and her doctorate from the University of St. Andrews.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
10/08/2023 107 433 ( 0.08% ) 2 M $ 31/03/2024
26/05/2023 56 250 ( 0.03% ) 83 250 $ 31/03/2024

Posizioni attive di Alison Hannah

SocietàPosizioneInizio
NEOGENOMICS, INC. Director/Board Member 12/06/2015
RIGEL PHARMACEUTICALS, INC. Director/Board Member 13/05/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member 01/09/2015
Tutte le posizioni attive di Alison Hannah

Precedenti posizioni note di Alison Hannah

SocietàPosizioneFine
CYTOMX THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 30/09/2022
Corporate Officer/Principal 01/09/2000
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Alison Hannah

Formazione di Alison Hannah

Harvard University Undergraduate Degree
University of St. Andrews Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Alison Hannah

Relazioni

100 +

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
NEOGENOMICS, INC.

Health Services

RIGEL PHARMACEUTICALS, INC.

Health Technology

CYTOMX THERAPEUTICS, INC.

Health Technology

Aziende private6

Health Technology

Health Services

Commercial Services

Commercial Services

Health Services

Health Services

Vedi le connessioni aziendali